313 related articles for article (PubMed ID: 17964409)
21. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterium interface keratitis after laser in situ keratomileusis.
Solomon A; Karp CL; Miller D; Dubovy SR; Huang AJ; Culbertson WW
Ophthalmology; 2001 Dec; 108(12):2201-8. PubMed ID: 11733259
[TBL] [Abstract][Full Text] [Related]
23. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis.
Chandra NS; Torres MF; Winthrop KL; Bruckner DA; Heidemann DG; Calvet HM; Yakrus M; Mondino BJ; Holland GN
Am J Ophthalmol; 2001 Dec; 132(6):819-30. PubMed ID: 11730644
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterium chelonae keratitis in a patient with Sjögren's syndrome.
Van Der Beek MT; Bernards AT; Lapid-Gortzak R
Eur J Ophthalmol; 2008; 18(2):294-6. PubMed ID: 18320526
[TBL] [Abstract][Full Text] [Related]
25. Bilateral Mycobacterium chelonae keratitis following LASIK.
Verma S; Watson SL; Dart JK; Eykyn SJ
J Refract Surg; 2003; 19(3):379-80. PubMed ID: 12777038
[No Abstract] [Full Text] [Related]
26. Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.
Varssano D; Waisbourd M; Berkner L; Regenbogen M; Hazarbassanov R; Michaeli A
Cornea; 2009 Jun; 28(5):586-8. PubMed ID: 19421033
[TBL] [Abstract][Full Text] [Related]
27. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
28. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
30. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
Deramo VA; Lai JC; Fastenberg DM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
[TBL] [Abstract][Full Text] [Related]
31. Atypical mycobacterium keratitis associated with penetrating keratoplasty: case report of successful therapy with topical gatifloxacin 0.3%.
Perez-Balbuena AL; Vanzzini-Zago V; Garza M; Cancino DC
Cornea; 2010 Apr; 29(4):468-70. PubMed ID: 20164758
[TBL] [Abstract][Full Text] [Related]
32. Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal.
Chung MS; Goldstein MH; Driebe WT; Schwartz BH
Am J Ophthalmol; 2000 Mar; 129(3):382-4. PubMed ID: 10704558
[TBL] [Abstract][Full Text] [Related]
33. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
Hu FR; Luh KT
Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
[TBL] [Abstract][Full Text] [Related]
34. Bilateral Non-tuberculous Mycobacterial Keratitis After Small Incision Lenticule Extraction.
Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
J Refract Surg; 2018 Sep; 34(9):633-636. PubMed ID: 30199569
[TBL] [Abstract][Full Text] [Related]
35. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME
Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
[TBL] [Abstract][Full Text] [Related]
36. Infectious keratitis outbreak after laser in situ keratomileusis at a single laser center in Japan.
Yamaguchi T; Bissen-Miyajima H; Hori-Komai Y; Matsumoto Y; Ebihara N; Takahashi H; Tsubota K; Shimazaki J
J Cataract Refract Surg; 2011 May; 37(5):894-900. PubMed ID: 21435830
[TBL] [Abstract][Full Text] [Related]
37. Bilateral Mycobacterium chelonae keratitis after laser in situ keratomileusis.
Sun YC; Wang IJ; Hu FR
Jpn J Ophthalmol; 2006; 50(3):285-7. PubMed ID: 16767388
[No Abstract] [Full Text] [Related]
38. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.
Girgis DO; Karp CL; Miller D
Clin Exp Ophthalmol; 2012 Jul; 40(5):467-75. PubMed ID: 21902780
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas keratitis after laser in situ keratomileusis.
Sharma N; Sinha R; Singhvi A; Tandon R
J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
